This Stock-Split Stock Is Beating Both Apple and Microsoft in 2023 -- With No Artificial Intelligence (AI) Tailwind at AllThe Motley Fool • 10/21/23
1 Thing You'd Better Know Before You Invest in the Stocks Behind Ozempic and MounjaroThe Motley Fool • 10/19/23
Together for CHANGE Genomics and Equity Initiative Launched by a Coalition of Meharry Medical College, Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche to Improve Health Outcomes for People of African AncestryBusiness Wire • 10/18/23
Novo Nordisk buys blood pressure treatment to bolster diabtetes portfolioProactive Investors • 10/16/23
Novo Nordisk Buys Hypertension Drug Ocedurenone For $1.3 Billion—Expanding Ozempic Maker's ArsenalForbes • 10/16/23
Novo Nordisk to buy hypertension treatment from for $1.3 billion from KBP BiosciencesMarket Watch • 10/16/23
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP BiosciencesGlobeNewsWire • 10/16/23
What exactly are patients taking new weight-loss drugs eating and what are they avoiding? Bernstein asked them.Market Watch • 10/13/23